ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
Jan-Ru Tang, Lainsu Kao, Jong-Rong Wang, Ruey-Yng Yuann
Nuclear Technology | Volume 129 | Number 1 | January 2000 | Pages 51-68
Technical Paper | Thermal Hydraulics | doi.org/10.13182/NT00-A3045
Articles are hosted by Taylor and Francis Online.
The very first work on RETRAN model development and its application to plant design study for the Lungmen nuclear power station (LMNPS) is presented. Lungmen is the fourth nuclear power plant of the Taiwan Power Company (TPC). LMNPS has two advanced boiling water reactor (ABWR) units, each with a thermal power of 3926 MW. The preliminary safety analysis report (PSAR) of LMNPS is currently under review. The Lungmen RETRAN-02/MOD5 model was developed to provide support to TPC in the PSAR review and system design study. An analysis of generator load rejection with failure of all bypass valves was performed against the analysis in the PSAR to benchmark the Lungmen RETRAN model. One of the specific designs of LMNPS is that the reactor has the capability to withstand a full-load rejection or a turbine trip event without a reactor scram. An analysis of generator load rejection with all bypass valves was done to evaluate this design. The results show that this design is appropriate.